Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury

A Phase III, double-blind, placebo-controlled trial (ProTECT III) found that administration of progesterone did not reduce mortality or improve functional outcome as measured by the Glasgow Outcome Scale Extended (GOSE) in subjects with moderate to severe traumatic brain injury. We conducted a secon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurotrauma
Main Authors: Goldstein, Felicia C., Caveney, Angela F., Hertzberg, Vicki S, Silbergleit, Robert, Yeatts, Sharon D., Palesch, Yuko Y., Levin, Harvey S., Wright, David W.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5198171/
https://ncbi.nlm.nih.gov/pubmed/26973025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/neu.2015.4313
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados